![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2036|41|5|459-466
ISSN: 0269-2813
Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.5, 2015-03, pp. : 459-466
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)